|
1）Hruska KA, Mathew S, Lund R, et al. Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008; 74: 148-57
|
|
|
|
2）Miyamoto K, Haito-Sugino S, Kuwahara S, et al. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. J Pharm Sci. 2011; 100: 3719-30
|
|
|
|
|
|
3）Quarles LD. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol. 2012; 8: 276-86
|
|
|
|
|
|
4）Kuro-o M. Klotho in health and disease. Curr Opin Nephrol Hypertens. 2012; 21: 362-8
|
|
|
|
|
|
5）Lederer E, Miyamoto K. Clinical consequences of mutations in sodium phosphate cotransporters. Clin J Am Soc Nephrol. 2012: 7: 1179-87
|
|
|
|
|
|
6）Magen D, Berger L, Coady MJ, et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi’s syndrome. N Engl J Med. 2010: 362: 1102-9
|
|
|
|
|
|
7）Cheng CY, Kuro-o M, Razzaque MS. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system. Adv Chronic Kidney Dis. 2011; 18: 91-7
|
|
|
|
|
|
8）De Beur SM, Finnegan RB, Vassiliadis J, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res. 2002; 17: 1102-10
|
|
|
|
|
|
9）Berndt T, Craig TA, Bowe AE, et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest. 2003; 112: 785-94
|
|
|
|
|
|
10）Carpenter TO, Ellis BK, Insogna KL, et al. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab. 2005; 90: 1012-20
|
|
|
|
|
|
11）Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Gent. 2006; 38: 1310-5
|
|
|
|
|
|
12）Rowe PS. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct. 2012; 30: 355-75
|
|
|
|
|
|
13）Berndt T, Thomas LF, Craig TA, et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sic U S A. 2007; 104: 11085-90
|
|
|
|
|
|
14）Datta HK, Malik M, Neely RD. Hepatic surgery-related hypophostatemia. Clin Chim Acta. 2007; 380: 13-23
|
|
|
|
|
|
15）Weinman EJ, Lederer ED. NHERF-1 and the regulation of renal phosphate reabsoption: a tale of three hormones. Am J Physiol Renal Physiol. 2012; 303: F321-7
|
|
|
|
|
|
16）Wang B, Means CK, Yang Y, et al. Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport. J Biol Chem. 2012; 287: 24148-63
|
|
|
|
|
|
17）Martin A, David V, Quarles LD. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012; 92: 131-55
|
|
|
|
|
|
18）Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 2012. (in press)
|
|
|
|
|
|
19）Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem. 2006; 281: 6120-3
|
|
|
|
|
|
20）Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444: 770-4
|
|
|
|
|
|
21）Farrow EG, Davis SI, Summers LJ, et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol. 2009; 20: 955-60
|
|
|
|
|
|
22）Razzaque MS. FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol. 2009; 296: F470-6. Review
|
|
|
|
|
|
23）Gattineni J, Bates C, Twombley K, et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009; 297: F282-91
|
|
|
|
|
|
24）Gattineni J, Twombley K, Goetz R, et al. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol. 2011; 301: F371-7
|
|
|
|
|
|
25）Hu MC, Shi M, Zhang J, et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 2010; 24: 3438-50
|
|
|
|
|
|
26）Cha SK, Hu MC, Kurosu H, et al. Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol. 2009; 76: 38-46
|
|
|
|
|
|
27）Chang Q, Hoefs S, van der Kemp AW, et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science. 2005; 310: 490-3
|
|
|
|
|
|
28）Cha SK, Ortega B, Kurosu H, et al. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A. 2008; 105: 9805-10
|
|
|
|
|
|
29）Martin DR, Ritter CS, Slatopolsky E, et al. Acute regulation of parathyroid hormone by dietary phosphate. Am J Physiol Endocrinol Metab. 2005; 289: E729-34
|
|
|
|
|